CRISPR edits fail to remedy HIV sufferers in early take a look at
BALTIMORE — An formidable effort to remedy HIV with CRISPR genome enhancing fell brief in an early scientific trial, investigators introduced Friday morning. Within the learn about, run via Excision BioTherapeutics, researchers